SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Transgene Biotek informs about outcome of board meeting

19 Aug 2021 Evaluate
Transgene Biotek has informed that meeting of the Board of Directors of the company held on 14th August 2021 the following decisions have been taken: It was decided to hold the 31st Annual General Meeting on Thursday the 30th September 2021 at 10.00 AM through Video Conferencing (VC )/ Other Audio Visual Means (OAVM); the Register of Members and Share Transfer Books of the Company will remain closed from Monday the 27th September 2021 to Wednesday the 29th September, 2021; and enclosed Unaudited financial results (Standalone and Consolidated) of the company for the quarter ended on 30.06.2021 along with the Limited Review Report (Standalone and Consolidated) by the Statutory Auditors of the Company.

The above information is a part of company’s filings submitted to BSE.

Transgene Biotek Share Price

3.10 0.22 (7.64%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 435.70
Indegene 486.80
CMS Info Systems 318.00
JITF Infralogistics 338.00
Sagility 42.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×